(Stroke. 2001;32:696.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Academic Unit of Psychiatry and Behavioural Sciences (A.H.) and the Division of Academic Pharmacy Practice, School of Healthcare Studies (P.K.), University of Leeds, Leeds, UK; the Department of Neurology (J.B.), St James University Hospital, Leeds, UK; and Hope Hospital (A.V.), University of Manchester, Manchester, UK.
Correspondence to Allan House, MD, MRCPsych, Professor in Liaison Psychiatry, Academic Unit of Psychiatry and Behavioural Sciences, University of Leeds, 15 Hyde Terrace, Leeds LS2 9LT, UK. E-mail a.o.house{at}leeds.ac.uk
| Abstract |
|---|
|
|
|---|
MethodsAs a cohort within a randomized controlled trial, 448 hospital patients were seen at 1 month after stroke and were randomized into a trial of psychological therapy. Follow-up was at 12 and 24 months. Mood symptoms were assessed by the Present State Examination and the General Health Questionnaire (GHQ)-28. Measures of disability before and after stroke and of cognitive impairment after stroke were also taken at 1 month. Mortality was determined at 12 and 24 months after stroke.
ResultsIn logistic regression analyses, mortality at 12 months was associated unifactorally with scoring on the GHQ-D subscale (odds ratio [OR] 2.4, 95% CI 1.3 to 4.5) and scoring in the highest quartile of the GHQ (OR 3.1, 95% CI 1.1 to 8.8). In multiple logistic regression analyses, only GHQ-D remained a significant predictor after controlling for other known predictors. At 24 months, scoring on GHQ-D (OR 2.4, 95% CI 1.4 to 4.1) and in the highest GHQ quartile (OR 2.2, 95% CI 1.0 to 4.8) was significantly associated with mortality in unifactoral analyses. Scoring on the GHQ-D remained a predictor of mortality after controlling for other variables. Psychiatric disorder, such as major depression (according to International Classification of Diseases, 10th Revision), was not statistically significantly associated with increased mortality at 12 or 24 months.
ConclusionsMood symptoms on a self-reported rating scale were associated with 12- and 24-month mortality after stroke, after adjustment for factors associated with stroke severity. The result is in keeping with other evidence that depressive symptoms are a risk factor for death from vascular disease.
Key Words: affect cohort studies depression mortality
| Introduction |
|---|
|
|
|---|
There have been fewer studies examining depression as a risk in stroke. A recently published cohort study from the United States found an increased mortality from stroke in people who had self-reported depressive symptoms at recruitment 29 years previously; this association remained significant after adjusting for known clinical and behavioral risk factors.8 Two small studies have reported that patients who were depressed in the early weeks after stroke had higher mortality at 15 months and at 10 years.9 10
If a causal link between depression and stroke mortality can be established, then it has clinical and theoretical implications; therefore, well-designed replications are needed. In the present study, we report a cohort enrolled within a randomized controlled trial, in which we examined the effect of depression identified 1 month after stroke on mortality at 12 and 24 months after stroke. Because of the findings of Lesperance et al,7 suggesting a role for depression symptoms below diagnostic criteria, we defined depression both by standardized clinical interview and the application of research diagnostic criteria and by scores on a self-reported questionnaire.
| Subjects and Methods |
|---|
|
|
|---|
Patients were assessed at 1 month after stroke and recruited
if they met the following criteria: definite clinical diagnosis of
stroke (not subarachnoid hemorrhage), sufficient speech
and use of English for interview (as judged by interviewer), sufficient
cognitive abilities to benefit from therapy (we defined this as
Mini-Mental State Examination [MMSE] score of
20 rather than the
usually quoted threshold13
because we were interested in the ability to participate in a simple
psychological therapy rather than in the presence of diagnosable but
mild cognitive impairment), local residence and living independently
before stroke, no concurrent illness likely to dominate the pattern of
care (approximately equivalent to Rankin handicap scores of 4 or
514 ), and written consent. We
did not recruit patients with subarachnoid hemorrhage,
because the trial was an evaluation of psychological intervention in
patients admitted to general medical and neurology wards rather than
those admitted under the care of neurosurgeons.
From an original stroke population of 1387 consecutive admissions, we excluded those with severe cognitive impairment (n=210) or language disorder (n=179) and those who were too ill to participate in the psychological therapy (n=269). Other exclusions were based on place of residence and involvement in other trials (n=187), and there were 92 refusals of consent to participate in the trial. There were 2 protocol violations leading to exclusion; therefore, the sample was composed of 448 hospitalized stroke patients who had been recruited to the trial.
Measures
Initial assessments were undertaken by a trained
research interviewer, who collected basic biographical data, including
age and whether the patient lived alone and could name a career.
History of previous stroke was obtained from the patient and the
medical record.
Physical functional status was assessed by using the Barthel
Index,15 a measure of
activities of daily living, which is scored 0 to 20, with higher scores
indicating greater independence. An assessment was made of the
patients poststroke and prestroke abilities. The Barthel Index may be
recoded to form categories: a score of 20 indicates no disability, and
scores of
12 are generally taken to indicate an ability to live
independently in the
community.16
The Frenchay Activities Index17 measures social function and is scored 0 to 45, with higher scores indicating greater social activity. Patients were asked to rate their prestroke activity. There are no published threshold scores, so we used the median score to categorize patients.
The MMSE is a measure of cognitive ability, designed originally to screen for dementia in the elderly. The measure is scored 0 to 30, with a lower score indicating greater cognitive impairment. A threshold score of <24 may be used to categorize patients as cognitively impaired.13
The General Health Questionnaire
(GHQ)-2818 is a measure of
general psychological distress and is scored 0 to 28, with higher
scores indicating greater distress. In neurological inpatients, scores
of
12 are taken to indicate the probable presence of psychiatric
disorder.19 Because this
threshold masks much variation, we also analyzed the GHQ-28 by
quartiles (scores 0 to 1, 2 to 5, 6 to 9, and 10 to 28). The GHQ-28
also has 4 subscales: somatic (A), anxiety and insomnia (B), social
dysfunction (C) and severe depression (D). There are no "caseness"
thresholds for the subscales, so we categorized patients by the median
score on each.
The short-form Present State Examination is a standardized semistructured psychiatric interview,20 which allows the reliable identification of psychiatric symptoms when it is administered by a trained interviewer, as in the present study. With minor additions to the interview, International Classification of Diseases, 10th Revision (ICD-10) psychiatric diagnoses can be derived from Present State Examination ratings; we used the ICD-10 research diagnostic criteria.21
Patient survival at 12 and 24 months was determined through general practitioners and checked, for untraceable patients, through the Office for National Statistics, which also provided certified causes of death. Data were analyzed by using SPSS 9.0.22
| Results |
|---|
|
|
|---|
|
Similar rates of depression were obtained by using the
different criteria used in the present study: 100 (22.3%) patients
met ICD-10 research criteria for major depression; 85 (19.1%)
patients scored above the probable "caseness" cutoff of
12 on the
GHQ-28. Depression at 1 month after stroke was significantly
associated, at the 95% level, with lower prestroke and 1-month
poststroke Barthel scores (see
Table 1
). Depression was also associated with being female,
with lower MMSE scores, and with being incontinent at 1 month after
stroke, but these associations did not reach statistical
significance.
Mortality at 12 Months
At 12 months, we were unable to establish the status of
2 patients who had moved abroad, leaving no contact details. Of the 446
traceable patients, 45 (10.1%) had died. Causes of death were as
follows: recurrent stroke in 17 (37.8%),
cardiovascular disease in 10 (22.2%), and other causes
in 18 (40.0%). No patient died as a result of suicide, and there was
no statistically significant difference between depressed and
nondepressed patients in the cause of death.
The relationship between independent variables assessed
at 1 month and mortality at 12 months was examined by logistic
regression. Independent variables were categorized (see Subjects
and Methods) and were assessed individually. All the mood measures
showed a trend for higher scores to be associated with increased
mortality, but only 2 measures (GHQ-D "severe depression" and GHQ
quartiles) were statistically significant. The odds ratio for mortality
was 3.1 between the lowest and highest scoring quartiles (see
Table 2
), with the rate of mortality 5% in the lowest
quartile and 14% in the highest (see
Figure 1
). Those scoring
1 on the GHQ-D severe depression
subscale had an odds ratio for mortality of 2.4 compared with those
scoring 0.
|
|
We conducted multiple logistic regression analyses to assess whether impaired mood was associated with increased mortality after controlling for the effects of recognized physical predictors (older age, lower MMSE scores, lower poststroke Barthel score, having suffered a previous stroke, and urinary incontinence). We did this separately for the GHQ quartiles and the GHQ-D subscale.
Multiple logistic regression showed that higher GHQ-D score,
greater age, lower MMSE scores, and lower poststroke Barthel scores
were all associated with an increased risk of dying within 12 months of
stroke (see
Table 3
). Other variables, including treatment
condition in the trial, were not significantly associated with
mortality. In a separate regression analysis, the statistically
significant effects of GHQ quartiles were lost after controlling for
other predictors (see
Table 4
).
|
|
Mortality at 24 Months
A further 20 patients had died between 12 and 24 months
after stroke, giving a total of 65 (14.6%) deaths for 446 patients in
24 months. As at 12 months, no patient had died as a result of
suicide.
As at 12 months, the relationship between independent
variables assessed at 1 month and mortality at 24 months was
examined by logistic regression. The GHQ quartiles and subscale GHQ-D
were statistically significantly associated with mortality; major
depression at 1 month was associated with mortality, but the result was
not statistically significant (see
Table 2
). Mortality among those in the lowest GHQ quartile
was 11% compared with a mortality of 23% among those in the highest
quartile (see
Figure 2
).
|
A multiple regression analysis assessed whether
impaired mood was an independent predictor of increased mortality after
controlling for the effects of recognized physical predictors, as at 12
months. This showed that the effects of scoring
1 on the GHQ-D
subscale remained statistically significant, even after controlling for
the effects of age, cognitive status, and known physical predictors
(see
Table 3
). The effects of the GHQ quartiles did not remain
statistically significant after controlling for other predictors (see
Table 4
).
| Discussion |
|---|
|
|
|---|
The strength of association between mood and mortality is considerably lower than that reported by Morris and colleagues.9 10 Does this result represent a true association, or could it be due to chance, bias, or confounding? We used several measures of mood in the analyses, raising the possibility of a false-positive result from multiple testing. The use of >1 mood measure was unavoidable if we were to test alternative hypotheses on the nature of depression, which predicts mortality, because previous research has suggested that either major depression or general psychological distress may be important. However, we cannot entirely exclude multiple testing as an explanation for our finding.
A second possibility is that bias may have affected the results. Observer bias is unlikely, because the significant mood measure was self-rated. Bias may result from studying hospital samples, when a spurious association can be found between variables that are both independently associated with risk of hospitalization (Berksons bias)23 ; this is unlikely, since multiple regression showed that the GHQ-D score was a predictor of mortality independent of measures of stroke severity. Mortality data were obtained for all but 2 patients, thus excluding bias from incomplete follow-up.
The third possibility is that there was residual confounding, particularly arising from an association between severity of physical illness and depressive symptoms, which was not detected through the available measures. Against this interpretation is our finding that the one significant GHQ subscale measured depressive thinking, whereas confounding of physical illness and somatic mood symptoms would be more likely in subscales A and C (somatic and social dysfunction items). Because of the nature of the study design, we were not able to assess all the stroke-related variables (eg, not every patient had a brain scan).
One possibility that we have not been able to explore is the confounding arising from a link between depressive symptoms after stroke and prior life events. It is possible that stressful life events might be a risk both for depression and for recurrent stroke or myocardial infarction.24
The mechanisms by which mood symptoms may be associated with increased mortality are behavioral or physiological. Suggested physiological explanations include alterations in autonomic control of cardiac rhythm (eg, those manifested by reduced heart rate variability)25 and increased platelet reactivity26 in depressed patients. Some support for this idea is provided by a meta-analysis of psychological treatments after myocardial infarction,27 which found that treatment not only reduced distress but also apparently led to lower blood pressure, heart rate, and cholesterol levels. Possible behavioral explanations include continued higher levels of smoking and alcohol consumption among depressed patients and lesser adherence to medical treatment.28 We were not able to measure all these factors (because of funding restrictions and problems of rater burden in a psychological treatment trial); therefore, the present study offers no evidence about the nature of any link that does exist.
One interesting implication of our results is that the psychological factor most strongly associated with mortality after stroke may not be depressed mood, per se, but general psychological distress or negative thoughts, such as feeling that life is not worth living or a feeling of personal worthlessness (items on the GHQ-D subscale). This finding is broadly in keeping with recent work into psychological predictors of mortality after myocardial infarction.6
This is the largest cohort study of mortality and depression after stroke. Its findings are ambiguous and therefore need replication, with further attempts to identify and adjust for confounders and more detailed characterization of psychological variables that might act as risk factors. At the same time, a descriptive study of the frequency of possible mediating variables (physiological and behavioral) in depressed and nondepressed stroke patients would help to clarify their possible involvement in any process whereby depressive symptoms have an impact on mortality after stroke.
| Acknowledgments |
|---|
Received July 8, 2000; revision received November 20, 2000; accepted November 20, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Hotopf, M. Henderson, and D. Kuh Invited Commentary: Stress and Mortality Am. J. Epidemiol., July 4, 2008; (2008) kwn147v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Robinson, R. E. Jorge, D. J. Moser, L. Acion, A. Solodkin, S. L. Small, P. Fonzetti, M. Hegel, and S. Arndt Escitalopram and Problem-Solving Therapy for Prevention of Poststroke Depression: A Randomized Controlled Trial JAMA, May 28, 2008; 299(20): 2391 - 2400. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Thomas and N. B. Lincoln Predictors of Emotional Distress After Stroke Stroke, April 1, 2008; 39(4): 1240 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Goodwin and D. P. Devanand Stroke, Depression, and Functional Health Outcomes Among Adults in the Community J Geriatr Psychiatry Neurol, March 1, 2008; 21(1): 41 - 46. [Abstract] [PDF] |
||||
![]() |
S. Hart and R. Morris Screening for depression after stroke: an exploration of professionals' compliancewith guidelines Clinical Rehabilitation, January 1, 2008; 22(1): 60 - 70. [Abstract] [PDF] |
||||
![]() |
F. Colivicchi, A. Bassi, M. Santini, and C. Caltagirone Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke Stroke, October 1, 2007; 38(10): 2652 - 2657. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Watkins, C. E. Lightbody, C. J. Sutton, L. Holcroft, C. I.A. Jack, H. A. Dickinson, M. D. van den Broek, and M. J. Leathley Evaluation of a single-item screening tool for depression after stroke: a cohort study Clinical Rehabilitation, September 1, 2007; 21(9): 846 - 852. [Abstract] [PDF] |
||||
![]() |
J. W. Gargano, M. J. Reeves, and for the Paul Coverdell National Acute Stroke Regis Sex Differences in Stroke Recovery and Stroke-Specific Quality of Life: Results From a Statewide Stroke Registry Stroke, September 1, 2007; 38(9): 2541 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Linden, C. Blomstrand, and I. Skoog Depressive Disorders After 20 Months in Elderly Stroke Patients: A Case-Control Study Stroke, June 1, 2007; 38(6): 1860 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Watkins, M. F. Auton, C. F. Deans, H. A. Dickinson, C. I.A. Jack, C. E. Lightbody, C. J. Sutton, M. D. van den Broek, and M. J. Leathley Motivational Interviewing Early After Acute Stroke: A Randomized, Controlled Trial Stroke, March 1, 2007; 38(3): 1004 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, J. J Guo, S. Zhan, and N. C Patel Treatment Effects of Antidepressants in Patients with Post-Stroke Depression: A Meta-Analysis Ann. Pharmacother., December 1, 2006; 40(12): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Paul, H. M. Dewey, J. W. Sturm, R. A.L. Macdonell, and A. G. Thrift Prevalence of Depression and Use of Antidepressant Medication at 5-Years Poststroke in the North East Melbourne Stroke Incidence Study Stroke, November 1, 2006; 37(11): 2854 - 2855. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Polsky, J. A. Doshi, S. Marcus, D. Oslin, A. Rothbard, N. Thomas, and C. L. Thompson Long-term Risk for Depressive Symptoms After a Medical Diagnosis Arch Intern Med, June 13, 2005; 165(11): 1260 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Hackett, C. S. Anderson, and A. O. House Management of Depression After Stroke: A Systematic Review of Pharmacological Therapies Stroke, May 1, 2005; 36(5): 1092 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, S. L. Norris, E. W. Gregg, Y. J. Cheng, G. Beckles, and H. S. Kahn Depressive Symptoms and Mortality among Persons with and without Diabetes Am. J. Epidemiol., April 1, 2005; 161(7): 652 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Kales, D. F. Maixner, and A. M. Mellow Cerebrovascular Disease and Late-Life Depression Am J Geriatr Psychiatry, February 1, 2005; 13(2): 88 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Spalletta, A. Ripa, and C. Caltagirone Symptom Profile of DSM-IV Major and Minor Depressive Disorders in First-Ever Stroke Patients Am J Geriatr Psychiatry, February 1, 2005; 13(2): 108 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Williams, S. S. Ghose, and R. W. Swindle Depression and Other Mental Health Diagnoses Increase Mortality Risk After Ischemic Stroke Am J Psychiatry, June 1, 2004; 161(6): 1090 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vataja, A. Leppavuori, T. Pohjasvaara, R. Mantyla, H. J. Aronen, O. Salonen, M. Kaste, and T. Erkinjuntti Poststroke Depression and Lesion Location Revisited J Neuropsychiatry Clin Neurosci, May 1, 2004; 16(2): 156 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.E. Schuitemaker, G.J. Dinant, G.A. Van Der Pol, A.F.M. Verhelst, and A. Appels Vital Exhaustion as a Risk Indicator for First Stroke Psychosomatics, April 1, 2004; 45(2): 114 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-L. Glader, B. Stegmayr, B. Norrving, A. Terent, K. Hulter-Asberg, P.-O. Wester, and K. Asplund Sex Differences in Management and Outcome After Stroke: A Swedish National Perspective Stroke, August 1, 2003; 34(8): 1970 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Charney, C. F. Reynolds III, L. Lewis, B. D. Lebowitz, T. Sunderland, G. S. Alexopoulos, D. G. Blazer, I. R. Katz, B. S. Meyers, P. A. Arean, et al. Depression and Bipolar Support Alliance Consensus Statement on the Unmet Needs in Diagnosis and Treatment of Mood Disorders in Late Life Arch Gen Psychiatry, July 1, 2003; 60(7): 664 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Jackson, H. D. Sesso, J. E. Buring, and J. M. Gaziano Alcohol Consumption and Mortality in Men With Preexisting Cerebrovascular Disease Arch Intern Med, May 26, 2003; 163(10): 1189 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E Ortiz Review: geriatric health services after discharge do not improve mental state in elderly people Evid. Based Ment. Health, May 1, 2002; 5(2): 45 - 45. [Full Text] [PDF] |
||||
![]() |
E.-L. Glader, B. Stegmayr, and K. Asplund Poststroke Fatigue: A 2-Year Follow-Up Study of Stroke Patients in Sweden Stroke, May 1, 2002; 33(5): 1327 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Robinson and R. Jorge Longitudinal Course of Mood Disorders Following Traumatic Brain Injury Arch Gen Psychiatry, January 1, 2002; 59(1): 23 - 24. [Full Text] [PDF] |
||||
![]() |
R. M. Carney and K. E. Freedland Psychological Distress as a Risk Factor for Stroke-Related Mortality Stroke, January 1, 2002; 33(1): 5 - 6. [Full Text] [PDF] |
||||
![]() |
L. Andre-Petersson, G. Engstrom, B. Hagberg, L. Janzon, G. Steen, D. A. Lane, D. Carroll, and G. Y.H. Lip Adaptive Behavior in Stressful Situations and Stroke Incidence in Hypertensive Men: Results From Prospective Cohort Study "Men Born in 1914" in Malmo, Sweden Editorial Comment: Results From Prospective Cohort Study "Men Born in 1914" in Malmo, Sweden Stroke, August 1, 2001; 32(8): 1712 - 1720. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||